Friendships are finally getting their due. Once relegated to a distant third position after life partners and children, a spate of new books are spotlighting the importance of friends. And research shows that people with close friends are healthier – both emotionally...
Purpose Prize
The Latest from CoGenerate
An Intergenerational Approach to Getting Families Housed in Santa Barbara
Lyiam Galo is the co-director of Generations United for Service, a program of the Northern Santa Barbara County United Way and one of 10 awardees of the CoGen Challenge to Advance Economic Opportunity. Watch for interviews with all 10 of these innovators bringing...
Utilizing Faith-Owned Land to Strengthen Intergenerational Community in Seattle
E.N. West is the co-founder and lead organizer of the Faith Land Initiative of the Church Council of Greater Seattle, one of 10 awardees of the CoGen Challenge to Advance Economic Opportunity. Watch for interviews with all 10 of these innovators bringing older and...
*
Daniel Luhata Shungu
Purpose Prize Fellow 2010
Shungu is working to purge onchocerciasis, a leading infectious cause of blindness, in the Democratic Republic of Congo through community-based distribution of medicine.
After a career with drug manufacturer Merck & Co., Daniel Luhata Shungu retired in 2002 to focus on eradicating onchocerciasis – also known as “river blindness” – a parasitic disease associated with irreversible blindness, severe itching, reduced life span, lizard-like skin and serious socioeconomic problems.
Seven million people are infected and approximately 70,000 are already blind or visually impaired in Shungu’s native Democratic Republic of Congo, where he is focusing his work. Once a person becomes blind, he or she becomes dependent on family members, especially children, who end up forgoing school to tend to their blind relatives.
Through training, capacity building and community empowerment, Shungu’s Lawrenceville, N.J.-based organization, United Front Against Riverblindness, is putting free medicine in the hands of local communities through designated community distributors who administer the drugs annually over a 10-year period to those affected. The distributors take personal responsibility for the success of the treatment and are in turn highly respected and recognized with gifts from their communities.
Nearly 1 million doses have been distributed so far. Early distribution success has encouraged Shungu to expand the efforts into new regions. Of his work, he says: “The satisfaction of realizing that the lives of many of the much less fortunate and previously helpless people in remote parts of Africa are being changed for the better is very hard to describe.”